Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.

Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.

2.

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O.

RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.

3.

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215882. doi: 10.1136/annrheumdis-2019-215882. [Epub ahead of print]

PMID:
31413005
4.

Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden.

Einarsson JT, Willim M, Saxne T, Geborek P, Kapetanovic MC.

Rheumatology (Oxford). 2019 Jul 13. pii: kez273. doi: 10.1093/rheumatology/kez273. [Epub ahead of print]

PMID:
31302705
5.

Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.

Vargas-Santos AB, Neogi T, da Rocha Castelar-Pinheiro G, Kapetanovic MC, Turkiewicz A.

Arthritis Rheumatol. 2019 Nov;71(11):1935-1942. doi: 10.1002/art.41008. Epub 2019 Sep 25.

PMID:
31169353
6.

The use of anthropometric measures in the prediction of incident gout: results from a Swedish community-based cohort study.

Wändell P, Andreasson A, Hagström H, Kapetanovic MC, Carlsson AC.

Scand J Rheumatol. 2019 Jul;48(4):294-299. doi: 10.1080/03009742.2019.1583368. Epub 2019 Apr 23.

PMID:
31012370
7.

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren's syndrome without disease modifying treatment.

Nived P, Saxne T, Geborek P, Mandl T, Skattum L, Kapetanovic MC.

BMC Rheumatol. 2018 Apr 5;2:12. doi: 10.1186/s41927-018-0019-6. eCollection 2018.

8.

The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.

Kapetanovic MC, Nilsson P, Turesson C, Englund M, Dalbeth N, Jacobsson L.

Arthritis Res Ther. 2018 Aug 29;20(1):190. doi: 10.1186/s13075-018-1697-6.

9.

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden.

Einarsson JT, Willim M, Ernestam S, Saxne T, Geborek P, Kapetanovic MC.

Rheumatology (Oxford). 2019 Feb 1;58(2):227-236. doi: 10.1093/rheumatology/key054.

PMID:
29538755
10.

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis.

Hesselstrand R, Nagel J, Saxne T, Geborek P, Skattum L, Kapetanovic MC.

Rheumatology (Oxford). 2018 Apr 1;57(4):769. doi: 10.1093/rheumatology/key007. No abstract available.

PMID:
29373696
11.

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis.

Hesselstrand R, Nagel J, Saxne T, Geborek P, Skattum L, Kapetanovic MC.

Rheumatology (Oxford). 2018 Apr 1;57(4):625-630. doi: 10.1093/rheumatology/kex471. Erratum in: Rheumatology (Oxford). 2018 Apr 1;57(4):769.

PMID:
29325173
12.

Do encourage your scleroderma patients at risk to get influenza vaccine.

Kapetanovic MC.

Rheumatology (Oxford). 2018 Oct 1;57(10):1691-1692. doi: 10.1093/rheumatology/kex380. No abstract available.

PMID:
29077976
13.

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies.

Einarsson JT, Evert M, Geborek P, Saxne T, Lundgren M, Kapetanovic MC.

Clin Rheumatol. 2017 Dec;36(12):2743-2750. doi: 10.1007/s10067-017-3848-6. Epub 2017 Oct 4.

14.

Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy.

Nived P, Nagel J, Saxne T, Geborek P, Jönsson G, Skattum L, Kapetanovic MC.

Vaccine. 2017 Jun 22;35(29):3639-3646. doi: 10.1016/j.vaccine.2017.05.044. Epub 2017 May 25.

PMID:
28552512
15.

Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.

Nagel J, Saxne T, Geborek P, Bengtsson AA, Jacobsen S, Svaerke Joergensen C, Nilsson JÅ, Skattum L, Jönsen A, Kapetanovic MC.

Lupus. 2017 Sep;26(10):1072-1081. doi: 10.1177/0961203317695465. Epub 2017 Feb 26.

PMID:
28420056
16.

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.

Lie E, Lindström U, Zverkova-Sandström T, Olsen IC, Forsblad-d'Elia H, Askling J, Kapetanovic MC, Kristensen LE, Jacobsson LTH.

Ann Rheum Dis. 2017 Sep;76(9):1515-1521. doi: 10.1136/annrheumdis-2016-210931. Epub 2017 Mar 2.

PMID:
28254789
17.

Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.

Kapetanovic MC, Nagel J, Nordström I, Saxne T, Geborek P, Rudin A.

Vaccine. 2017 Feb 7;35(6):903-908. doi: 10.1016/j.vaccine.2016.12.068. Epub 2017 Jan 9.

PMID:
28081972
18.

Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective.

Kapetanovic MC, Hameed M, Turkiewicz A, Neogi T, Saxne T, Jacobsson L, Englund M.

RMD Open. 2016 Nov 1;2(2):e000326. eCollection 2016.

19.

Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.

Einarsson JT, Geborek P, Saxne T, Kristensen LE, Kapetanovic MC.

J Rheumatol. 2016 Jun;43(6):1017-23. doi: 10.3899/jrheum.150995. Epub 2016 Apr 1.

PMID:
27036384
21.

The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.

Nagel J, Geborek P, Saxne T, Jönsson G, Englund M, Petersson IF, Nilsson JÅ, Truedsson L, Kapetanovic MC.

Arthritis Res Ther. 2015 May 19;17:124. doi: 10.1186/s13075-015-0636-z.

22.

Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.

Einarsson JT, Geborek P, Saxne T, Kapetanovic MC.

J Rheumatol. 2015 May;42(5):741-8. doi: 10.3899/jrheum.131502. Epub 2015 Feb 15.

PMID:
25684762
23.

The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.

Nagel J, Geborek P, Saxne T, Jönsson G, Englund M, Petersson IF, Nilsson JÅ, Kapetanovic MC.

Scand J Rheumatol. 2015;44(4):271-9. doi: 10.3109/03009742.2014.984754. Epub 2015 Feb 6.

PMID:
25656734
24.

Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years: relation to disease activity, joint damage, and comorbidity.

Kapetanovic MC, Lindqvist E, Nilsson JÅ, Geborek P, Saxne T, Eberhardt K.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):340-8. doi: 10.1002/acr.22458.

25.

Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden.

Gulfe A, Kapetanovic MC, Kristensen LE.

Scand J Rheumatol. 2014;43(6):493-7. doi: 10.3109/03009742.2014.918173. Epub 2014 Aug 22.

PMID:
25145283
26.
27.

Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts.

de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, van der Heijde DM, Gregersen PK, Lindqvist E, Huizinga TW, Gröndal G, Svensson B, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Jul;73(7):1384-7. doi: 10.1136/annrheumdis-2013-203940. Epub 2014 Jan 3.

PMID:
24389296
28.

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P.

Arthritis Res Ther. 2014 Jan 2;16(1):R2. doi: 10.1186/ar4427.

30.

Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.

Kapetanovic MC, Roseman C, Jönsson G, Truedsson L.

Clin Rheumatol. 2011 Dec;30(12):1555-61. doi: 10.1007/s10067-011-1856-5. Epub 2011 Sep 29.

PMID:
21956234
31.
32.

Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.

Kapetanovic MC, Lindqvist E, Geborek P, Saxne T, Eberhard K.

Scand J Rheumatol. 2011 Nov;40(6):433-8. doi: 10.3109/03009742.2011.573503. Epub 2011 May 30.

PMID:
21619489
33.

Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis.

Kapetanovic MC, Lindqvist E, Algulin J, Jonsson K, Saxne T, Eberhardt K, Geborek P.

Arthritis Res Ther. 2011 Feb 23;13(1):R31. doi: 10.1186/ar3259.

34.

Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.

Kapetanovic MC, Lindqvist E, Simonsson M, Geborek P, Saxne T, Eberhardt K.

Scand J Rheumatol. 2010;39(5):353-9. doi: 10.3109/03009741003674180.

PMID:
20615160
35.

Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Bengtsson C, Kapetanovic MC, Källberg H, Sverdrup B, Nordmark B, Klareskog L, Alfredsson L; EIRA Study Group.

Ann Rheum Dis. 2010 Oct;69(10):1831-3. doi: 10.1136/ard.2010.129908. Epub 2010 Jul 5.

PMID:
20603497
36.

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.

Kristensen LE, Kapetanovic MC, Gülfe A, Söderlin M, Saxne T, Geborek P.

Rheumatology (Oxford). 2008 Apr;47(4):495-9. doi: 10.1093/rheumatology/ken002. Epub 2008 Mar 3.

PMID:
18316338
37.

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.

Karlsson JA, Kristensen LE, Kapetanovic MC, Gülfe A, Saxne T, Geborek P.

Rheumatology (Oxford). 2008 Apr;47(4):507-13. doi: 10.1093/rheumatology/ken034. Epub 2008 Feb 27.

PMID:
18304941
38.

Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement.

Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K.

Ann Rheum Dis. 2008 Oct;67(10):1412-6. doi: 10.1136/ard.2007.086710. Epub 2008 Jan 4.

PMID:
18178691
39.

The impact of IL-1Ra and MBL gene polymorphisms on joint damage after 5 and 10 years in patients with early rheumatoid arthritis.

Kapetanovic MC, Lindqvist E, Sturfelt G, Saxne T, Truedsson L, Eberhardt K.

J Rheumatol. 2007 Apr;34(4):894-5. No abstract available.

PMID:
17407253
40.

[Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication].

Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T.

Ugeskr Laeger. 2007 Jan 29;169(5):420-3. Danish.

PMID:
17280636
41.
42.

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

Kapetanovic MC, Saxne T, Nilsson JA, Geborek P.

Rheumatology (Oxford). 2007 Apr;46(4):608-11. Epub 2006 Nov 18.

PMID:
17114801
43.

Predictors of infusion reactions during infliximab treatment in patients with arthritis.

Kapetanovic MC, Larsson L, Truedsson L, Sturfelt G, Saxne T, Geborek P.

Arthritis Res Ther. 2006;8(4):R131.

44.

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.

Rheumatology (Oxford). 2006 Jan;45(1):106-11. Epub 2005 Nov 15.

PMID:
16287919
45.

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

Jacobsson LT, Turesson C, Gülfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P.

J Rheumatol. 2005 Jul;32(7):1213-8.

PMID:
15996054

Supplemental Content

Loading ...
Support Center